Walter Stummer

13PUBLICATIONS
29CO-AUTHORS
Cellular nervous systemExercise physiologyBiogeography and phylogeographyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 14, 2026
Apoptosis and Glial Marker Profiles in Hippocampus and Amygdala of Medically Intractable Temporal Lobe Epilepsy.

|Jul 29, 2025
Enhancing cardiorespiratory fitness and quality of life in high-grade glioma through an intensive exercise intervention during chemotherapy: Proof of concept.

Johanna Jost-Engl, Ralf Ketter, Ralf Brandt

|May 12, 2025
Blood group O attributes to prolonged progression-free survival, overall survival, and 5-year survival in isocitrate dehydrogenase-wildtype glioblastoma patients with MGMT promoter methylation.

Rainer Wiewrodt, Maren Kloss, Johanna Jost-Engl

|Apr 23, 2025
Synthetic O-(2-18F-fluoroethyl)-l-tyrosine-positron emission tomography generation and hotspot prediction via preoperative MRI fusion of gliomas lacking radiographic high-grade characteristics.

Eric Suero Molina, Mehnaz Tabassum, Ghasem Azemi

|Oct 01, 2024
Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with lomustine/temozolomide.

Thomas Zeyen, Laura Böhm, Daniel Paech

|Apr 02, 2024
Beyond fluorescence-guided resection: 5-ALA-based glioblastoma therapies.

Walter Stummer, Michael Müther, Dorothee Spille

Pageof 3

Frequent Collaborators

3 joint publications

Dorothee Wiewrodt

2 joint publications

Johanna Jost-Engl

1 joint publications

Daniel A Orringer

1 joint publications

Stephanie Schipmann